BioRestorative Therapies (BRTX) Stock Makes an Interesting Move: Now What?

September 3, 2021

Life science Company focusing on stem cell-based therapies, BioRestorative Therapies (OTCMKTS:BRTX) on September 2, 2021, announced that the Australian Patent Office issued a patent pertaining to the metabolic ThermoStem Program. Claims under the fresh patent include implantable scaffold as well as brown adipocytes from brown adipose of human-derived stem cells besides methods of use. A type of fat tissue in humans, Brown adipocytes regulates metabolic activity. The initial preclinical research demonstrates…

Read More >>